• Sector-wise market news update-July 11, 2025

    Financial Services & Banking
    • State Bank of India is planning a massive QIP of ₹25,000 crore (~$2.9 bn) aimed at institutions, following board approval in May
    • Sebi launched “Bond Central,” a centralised platform expected to deepen India’s corporate bond market with improved price discovery and accessibility

    Technology / IT / Consulting
    • Tata Consultancy Services (TCS) posted a muted Q1 result: revenues rose just 1.3% YoY in INR (–3.1% CC). Brokers have cut FY26 estimates, and the stock and peers (Infosys, Wipro) are under pressure
    • Weak Q1 earnings from TCS and fresh U.S. tariffs are weighing on IT stocks, dragging Sensex/Nifty futures lower

    Equity & IPO Market
    • India is on track for a record IPO year: $6.7 bn raised YTD, with July expected to bring in another $2.4 bn. Major upcoming deals include Tata Capital (~$2 bn), LG Electronics, Credila, NSDL, JSW Cement, and others

    Financials & Fundraising Plans
    • South Indian Bank: Board meeting on July 17 to consider equity fund raise.
    • State Bank of India (SBI): Board meeting on July 16 to consider raising Basel III bonds.
    • M&M Financial Services: Approved ₹100 crore via NCDs on private placement.

    Energy, Infrastructure & Industrials
    • Capgemini to acquire India’s BPO giant WNS for $3.3 bn, pushing deeper into AI-enabled services
    • Hindustan Unilever appoints Priya Nair as new CEO & MD; Tata Elxsi also delivers below expected earnings; Zee Entertainment’s warrants issuance plan stalls
    • MP Growth Conclave in Indore will showcase ₹10,000  crore urban infrastructure projects, boosting sectors like smart cities and urban mobility

    Market Sentiment & Global Cues
    • GIFT Nifty futures indicate a ~0.5% gap down start amid global trade uncertainty, bearish cues from U.S. tariffs and corporate earnings

    Stocks to Watch
    Top names in focus: TCS, IREDA, Zee, HUL, Tata Steel, Glenmark Pharma, DMart — driven by news flow, Q1 earnings and sectoral headlines

    Technical & Analyst Views
    • Market volatility is at a 52 week low (India VIX), offering calmer trading conditions
    • Aditya Birla Sun Life AMC and One97 Communications (Paytm) are top picks, with technical buy signals and attractive valuations

    Key Quarterly Results & Business Updates
    Tata Consultancy Services (TCS) – Q1 FY26 (Consolidated, QoQ)
    • Revenue: ₹63,437 crore, down 1.6% from ₹64,479 crore
    • EBIT: ₹15,514 crore, down 1%
    • EBIT Margin: 24.5% vs 24.2%
    • Net Profit: ₹12,760 crore, up 4.4%
    • Total Contract Value: $9.4 billion vs $12.2 billion
    • Attrition (LTM): 13.8% vs 13.3%
    • Robust deal closures and strong performance across new services.

    Anand Rathi Wealth – Q1 FY26
    • Revenue: ₹274 crore (↑23.4% QoQ, ↑15% YoY)
    • Net Profit: ₹93.91 crore (↑27.4% QoQ, ↑27.9% YoY)
    • PAT: ₹126 crore (↑27.3% QoQ)
    • AUM: ₹87,797 crore, up 27% YoY
    • FY26 Guidance: Revenue ₹1,175 crore, Profit ₹375 crore, AUM ₹1 lakh crore

    IREDA – Q1 FY26 (Consolidated, YoY)
    • Net Interest Income (NII): ₹691 crore, up 36%
    • Net Profit: ₹247 crore, down 35.7%
    • Gross NPA: 4.13% vs 2.45% (QoQ)
    • Net NPA: 2.06% vs 1.35% (QoQ)
    • Impairment: ₹363 crore, up 180%
    • Loan Book: ₹79,941 crore, up 26%
    • Net Interest Margin: 3.6% vs 3.27%

    Tata Elxsi – Q1 FY26 (QoQ)
    • Revenue: ₹892.1 crore, down 1.8%
    • EBIT: ₹162.4 crore, down 11%
    • Margin: 18.2% vs 20.1%
    • Net Profit: ₹144.4 crore, down 16%
    • Segment Revenue:
    o Transportation: ↑3.7% QoQ
    o Media & Communication: ↓5.5% QoQ (cc)

    Leadership Changes
    • Hindustan Unilever (HUL): MD & CEO Rohit Jawa to step down on July 31. Priya Nair appointed as new MD & CEO effective August 1 for 5 years.

    Pharmaceuticals & Healthcare
    • Glenmark Pharma: Subsidiary IGI Therapeutics signs a global licensing agreement with AbbVie for cancer drug ISB 2001.
    o Deal includes $700 million upfront and up to $1.225 billion in milestone payments.
    o Drug is in Phase I clinical trials.
    • Emcure Pharma: USFDA concluded pre-approval inspection of oncology unit in Gujarat with zero observations.

    Media & Entertainment
    • Zee Entertainment: Shareholders rejected the ₹2,237 crore warrant issue to promoters.
    o 59.5% voted in favor, below the required threshold for approval.

    Corporate & Strategic Updates
    • Prestige Estates: Issued a corporate guarantee for JV Thomsun Realtors’ term loan.
    • PC Jeweller: Raised ₹500 crore via preferential allotment.
    • Ircon International: Faced a ₹72.9 crore claim by SA Yadav at Arbitral Tribunal.
    • Mphasis: Acquired 26% stake in U.S.-based Aokah for $4 million.
    • Consolidated Construction: Received ₹200 crore order for factory and building projects.